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The fear of cancer recurrence is cited as a motivator of women’s preferences between routine 
monitoring or contralateral prophylactic mastectomy (CPM) as methods of managing ongoing breast 
cancer risk.  We conducted a discrete choice experiment among a general community sample of 
women who completed 12 hypothetical choices between routine monitoring or CPM described by 
aspects of treatment efficacy, safety, cost and involvement in decision making.  Respondents also 
completed a modified cancer worry question to assess cancer concern. 
57.5% of 464 women always chose one option, typically routine monitoring.  The majority (71.5%) 
reported being concerned about cancer recurrence when completing choice tasks.  Latent class 
analysis identified three groups: preferred routine monitoring; preferred CPM; and ‘traders’ (willing 
to swap between options).  Among traders, women were less likely to choose an option associated 
with higher risk of recurrence.  Women were more likely to choose options associated with less 
intrusive monitoring methods and where they were involved in decision-making.  Women concerned 
about cancer recurrence were more likely to choose CPM over monitoring.   
This study shows that women’s preferences about how to manage breast cancer recurrence risk reflect 
the importance of the associated health effects, experience of care and attitudes to cancer recurrence.   
  




In a Consensus Statement, the American Society of Breast Surgeons highlighted that growth in the 
use of contralateral prophylactic mastectomy (CPM) has been in part driven by the preferences of 
women with breast cancer (J. C. Boughey, Attai, Chen, Cody, Dietz, Feldman, Greenberg, Kass, 
Landercasper, Lemaine, MacNeill, Song, et al., 2016).  The Society and others (J. Boughey et al., 
2010; J. C. Boughey, Attai, Chen, Cody, Dietz, Feldman, Greenberg, Kass, Landercasper, Lemaine, 
MacNeill, Margenthaler, et al., 2016; J. C. Boughey, Attai, Chen, Cody, Dietz, Feldman, Greenberg, 
Kass, Landercasper, Lemaine, MacNeill, Song, et al., 2016; Fayanju, Stoll, Fowler, Colditz, & 
Margenthaler, 2014; Fisher et al., 2012; Lostumbo, Carbine, & Wallace, 2010; Rosenberg et al., 2013; 
Sando et al., 2018; Spillaine, 2016; Tuttle, Abbott, Arrington, & Rueth, 2010) note that, for some 
women, these preferences reflect a desire to reduce the fear or anxiety associated with cancer 
recurrence.  The choice to undergo CPM might also reflect a woman’s preferences regarding follow-
up breast cancer care, in particular, complying with intensive monitoring regimens, or the influence of 
follow-up care on body image and sexual identity (Rosenberg et al., 2013; Spillaine, 2016).   
CPM has been shown to be associated with increases in health care use, largely due to the associated 
surgery and subsequent breast reconstruction (Deshmukh et al., 2014).  As this increased use of health 
care does not necessarily improve breast cancer health outcomes (J. C. Boughey, Attai, Chen, Cody, 
Dietz, Feldman, Greenberg, Kass, Landercasper, Lemaine, MacNeill, Song, et al., 2016; Pauker & 
Alseiari, 2014; Spillaine, 2016), there is a need to better understand what is influencing women’s 
preferences and values for CPM.  One way to understand such preferences is through the use of 
discrete choice experiments (DCE).  DCEs are a widely used technique in marketing, environmental 
and transport economics that are being increasingly applied to choices in health care (Clark, 
Determann, Petrou, Moro, & de Bekker-Grob, 2014).  In a DCE the intervention of interest is 
described by its characteristics, called attributes e.g. cancer risk.  A survey is constructed that presents 
respondents with a series of choice sets described by one or more choice profiles, which present 
hypothetical but realistic combinations of these attributes.  Within each choice set, survey respondents 
are asked to make choices about which profile they would choose.  Analysis of these repeated choices 
and how respondents trade-off their choices between profiles reveals the value individuals place on 
specific attributes (A. Muhlbacher & F. R. Johnson, 2016).   
In this study, we used a DCE to understand what influenced the preferences of a general community 
sample of women for the management of the risk of cancer recurrence in the context of early breast 
cancer.  We examined how women’s choices between profiles describing routine monitoring and the 
use of CPM following treatment for early breast cancer were affected by the attributes describing 
those profiles, as well as by their demographic characteristics and concerns regarding cancer 
recurrence.  The results presented in this paper focus on the key factors influencing women’s choices 
and what influence concern about cancer recurrence has on decisions regarding the management of 
breast cancer risk.  
Methods 
DCE Design 
The attributes and levels included in the DCE survey were developed using information from the 
existing literature on breast cancer (Benning, Kimman, Dirksen, Boersma, & Dellaert, 2012; Bessen 
et al., 2014; J. Boughey et al., 2010; Fallowfield, McGurk, & Dixon, 2004; Kimman, Dellaert, 
Boersma, Lambin, & Dirksen, 2010; Rosenberg et al., 2013; Yi et al., 2010) and the results of 
qualitative research with two groups of women who had previously undergone treatment for early 
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stage breast cancer (n=11).  While the choices of some participants in those focus groups centred on 
reducing the likelihood of future cancer recurrence, others focussed on the process of care - reflected 
in a lack of trust in the standard methods of monitoring, or avoidance of the intrusiveness of ongoing 
monitoring e.g. mammography, and the negative effects of surgical intervention (such as pain and the 
loss of breast sensitivity).  One of the key themes that emerged was the influence on women’s 
decisions of anxiety associated with a fear of cancer recurrence and anticipatory anxiety associated 
with testing of the unaffected breast; some women described a desire to reduce anxiety or a fear of 
recurrence as motivators for their decision to have a CPM.   
In developing the attributes for the DCE, it was not considered possible to conceptualise an attribute 
that directly conveyed fear of recurrence or anticipatory anxiety because these reflect a respondent’s 
individual perceptions.  Rather, these effects were incorporated via attributes describing the likelihood 
of future cancer (the risk of contralateral breast cancer and the risk of ipsilateral or metastatic breast 
cancer, as measures of fear of recurrence) and the mode and frequency of ongoing monitoring (for 
anticipatory anxiety).  The other attributes included were: the risk of pain; the risk of losing breast 
sensitivity; involvement in decision making; and out-of-pocket (OOP) costs for routine monitoring 
and CPM surgery.  Three attributes, risk of pain, risk of losing breast sensitivity and OOP for CPM 
surgery, were specific to the CPM option (see Table 1).  The range of attributes and possible levels 
were refined following a pilot survey with 87 women recruited from an online general community 
panel provider (PureProfile, 2014).   
The total number of intervention profiles that could be described by the combination of these 
attributes was prohibitively large (over 55,000).  Accordingly, these were reduced to a manageable 
number that was also mathematically efficient (a C-efficient design was used to it minimised the 
variance of the ratio of how women responded to the cost of monitoring and any other attribute), 
using the computer design program Ngene and the choice values obtained from the pilot study (A. 
Muhlbacher & F. Johnson, 2016; Rose, Collins, Bliemer, & Hensher, 2012).  This resulted in a design 
that comprised a total of 48 choice sets, with each respondent randomly allocated to see 12.  In each 
choice set, respondents chose between two methods of managing ongoing breast cancer recurrence 
risk, labelled as ‘Surgery to remove unaffected breast plus monitoring’ and ‘Routine monitoring 
only’.  The design of this experiment meant that the choice profiles were “labelled” since some 
attribute levels only appeared in one option e.g. surgical OOP costs were only relevant for the CPM 
option, thus respondents were effectively not blinded to the profiles.  An example of a choice set, 
including the choice labels, is provided at Box 1. 
Each survey also included a background vignette describing the choice scenario.  Respondents were 
randomised to three versions of the survey to test the influence on women’s choices of varying how 
the risks of cancer recurrence were presented and the amount of information in the background 
vignette.  The allocation of respondents to versions was balanced, and subsequent testing showed that 
the results could be combined across versions (results available on request).  The results presented in 
this paper are from the pooled analysis.   
Cancer Concern and Demographics 
In addition to completing all 12 choice sets, respondents were also asked to answer demographic 
questions and to rate the extent to which they were concerned about the choice attributes while they 
were completing the survey.  Based on a modified cancer worry scale (Campbell, Marbella, & Layde, 
2000; Custers et al., 2014; Spencer et al., 1999; Thewes et al., 2012), respondents were asked to rate 
each of the choice attributes (cancer recurrence, costs of care, the type and frequency of monitoring, 
pain or loss of breast sensitivity, and involvement in decision making) against the question: “How 
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much did concern or worry about each of the following factors influence the choices you made?”  
Responses were rated on a five-point scale from not at all (1) to extremely (5) concerned; ratings from 
1-3 were categorised as being not concerned about an attribute, and ratings of 4-5 were categorised as 
concerned.  While concern about cancer recurrence was the primary measure of interest for this 
question, the other four factors were included to reduce the potential for respondents to unduly focus 
on cancer recurrence in their responses.  The demographic characteristics for respondents classified as 
being concerned and not concerned were summarised and compared using Fisher’s Chi2 test.  
Analysis of Results 
Typically, the analysis of DCE surveys assesses the relationship between the choices respondents 
make and the differences in the attributes that were used to describe profiles resulting in those choices 
(Greene, 2008; Johnson et al., 2013; A. Muhlbacher & F. Johnson, 2016).  Based on the results of the 
qualitative research and pilot survey, we hypothesised that we could categorise women into groups 
based on the similarity of their preferences, or how they made choices, between routine monitoring 
and CPM.  Given the potential for such groups to exist, we used latent class analysis (Pacifico & Yoo, 
2013), similar to cluster analysis, to analyse the choices women made. This assumes that the 
probability an individual will choose a particular option is conditional on them belonging to a 
particular group and is a widely-used in the analysis of choices in health care (Zhou, Thayer, & 
Bridges, 2018).  The latent class analysis tested the likelihood that women belonged to a given group 
based on their demographic characteristics (age, household income, education), whether they were 
concerned about cancer recurrence when completing the choice tasks, their prior participation in 
cancer screening, and accounting for the pooled nature of the survey.  The specification of this 
analysis is described in the technical appendix.  The resulting coefficients from this analysis, which 
show the strength of preference for attributes influencing choice, are reported as odds ratios (OR).  All 
analyses were conducted using Stata 12.  
Respondent Recruitment 
Both the pilot and final surveys were administered online to women aged 18 years or older registered 
with the online panel company PureProfile (PureProfile, 2014).  Women were recruited to the survey 
by means of an invitation sent directly to each potential respondent’s PureProfile home page; 
participation was by self-selection.  PureProfile was reimbursed per respondent (approximately $10-
15 per survey), part of which was passed onto respondents.  This study was approved by the UTS 
Human Research Ethics Committee (HREC 2015000161). 
Results 
The Participants 
A total of 464 respondents completed the survey (Table 2).  Compared to the Australian population a 
higher proportion of respondents were in the middle age groups and better educated; however, 
respondents were similar to the Australian population in terms of income and geographic location 
(Australian Bureau of Statistics (ABS), 2015a, 2015b, 2015c).  Respondents’ participation in all types 
of cancer screening, in all age groups, was less than 40% when restricted to the previous two-year 
period – the interval of interest for both the National Cervical Screening and Breast Cancer Screening 
programs in Australia.  This is lower than screening participation among the general population of 
Australian women; data from the Australian Institute of Health and Welfare show that 54% of women 
aged 50-69 had a mammogram, 57% of those aged 20-69 had a Pap test, and 38.5% of those aged 50-
65 had been screened for bowel cancer in the last two years (Australian Institute of Health and 
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Welfare, 2014, 2016).  Lower rates of screening participation among survey respondents suggests 
that, compared to the general population of Australian women, they might be willing to accept more 
risk as it pertains to cancer, or are less concerned about cancer occurrence. 
Attribute Importance and Concern 
Respondents rated the risk of recurrence of contralateral (22.6%) and ipsilateral/metastatic (18.7%) 
breast cancer as the two most important attributes affecting their choices, while the risk of losing 
breast sensitivity (28.7%) was the least important.   
Most respondents (71.5%) reported being concerned about cancer recurrence when completing the 
choice tasks.  Respondents were either not concerned about the remaining attributes, or the numbers 
of respondents concerned or not concerned about individual attributes were approximately equal.  
Women reporting concern about cancer recurrence differed from those not concerned in terms of all 
the demographic factors included (age, income, education, region of residence – p<0.001 for all 
factors).  In particular, more respondents who were concerned about recurrence had a university 
degree (32.5%) compared with those who were not concerned (26.5%), with corresponding 
differences in the proportion of those with a vocational education (36.2% and 45.4% respectively).  In 
addition, a higher proportion of respondents who were concerned about cancer recurrence (68.7%) 
lived in a major city compared with those who were not concerned (63.1%).  Ratings of attribute 
importance differed between respondents based on cancer concern:  those who were concerned rated 
the risk of recurrence (CBC or Other risk) as most important, while respondents who were not 
concerned about cancer recurrence, reported that the most important attribute was involvement in 
decision-making (see Figure 1).  Both groups rated the risk of losing breast sensitivity as the least 
important attribute. 
Choice Behaviour 
An interesting feature of this choice experiment is that the majority of respondents (57.5%) always 
chose one option, typically routine monitoring (49.1%), with fewer preferring CPM (8.4%).  In DCE 
parlance, this is referred to as ‘non-trading’.  Based on standard information criteria (Pacifico & Yoo, 
2013), the latent class analysis identified three groups of respondents:  Prefer CPM (12% of women) 
who indicated a preference for CPM in the majority of choices; Prefer Monitoring (59%) who 
preferred routine monitoring in the majority of choices; and Traders (29%) who were prepared to 
swap between CPM and routine monitoring.  The factors influencing choice as described by the latent 
class analysis are reported in Table 3. 
Respondents in the Prefer CPM group were influenced by the alternative specific constant 
(management compared with CPM; OR=0.24, p=0.073), indicating that they were more likely to 
choose CPM than routine monitoring.  Respondents in the Traders group were not influenced by the 
alternative specific constant (p=0.291), but were less likely to choose options with higher breast 
cancer risk (OR=0.81, p<0.001 for contralateral risk; OR=0.96, p=0.01 ipsilateral/metastatic risk), 
pain risk (OR=0.99, p=0.02), or monitoring (OR=0.95, p<0.001) and surgical OOP costs (OR=0.99, 
p<0.001).  They were more likely to choose options in which they were always involved in decisions 
about their care (OR=1.14, p=0.001).  Finally, respondents in the Prefer Monitoring group showed a 
strong preference for routine monitoring indicated by the significant OR for the alternative specific 
constant (OR=5.26, p<0.01).  Despite strong preferences for routine monitoring, some respondents in 
this group were less likely to choose options with higher monitoring costs (OR=0.91, p=0.032) and 
surgical OOP costs (OR=0.99, p=0.008), the latter applying to the CPM option only. 
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Inclusion of the demographic variables in the factors determining class membership showed that 
overall, respondents were less likely to belong to either the Prefer CPM (OR=0.043, p<0.001) or 
Traders groups (OR=0.343, p<0.001) than the Prefer Monitoring group.  Younger respondents (aged 
16-25 years) were more likely than those aged 25-45 to be Traders compared to Prefer Monitoring, 
while those 45-65 years of age were more likely than 25-45 year olds to Prefer CPM compared with 
Prefer Monitoring.  In general, respondents who were cancer concerned were less likely to be in the 
Prefer Monitoring group compared with either of the other two groups (p<0.001).  
Discussion 
There is often discussion in the popular and academic press about the importance of early detection 
and treatment as a means of reducing the effects of breast cancer.  Early detection and treatment of 
recurrence is also important for women who have experienced breast cancer; how women choose to 
manage their ongoing risk of recurrence has implications not only for their risk of cancer recurrence, 
but also for their ongoing experience of care, and the subsequent utilisation and costs of that care.  
The importance of these issues was discussed by women participating in the qualitative work 
underpinning this research and is consistent with the results of previous research regarding the factors 
motivating women’s decisions about CPM (Altschuler et al., 2008; Fisher et al., 2012; Rosenberg et 
al., 2013; Sando et al., 2018). 
In a recently published cohort study of outcomes in early-onset breast cancer, Copson et al (2018) 
concluded that decisions regarding risk reducing strategies, such as CPM, should not only take into 
account ongoing cancer risk but also patient preferences (Copson et al., 2018).  Our results show that 
a majority of women have strongly held preferences; they favour routine monitoring when choosing 
how they would manage the ongoing risk of cancer recurrence.  It is possible that this reflects a 
willingness among these women to accept more risk as it pertains to cancer recurrence.  The fact that 
women in our study reported lower rates of participation in national cancer screening programs than 
those of a similar age suggests that they may be willing to accept higher cancer risks than the general 
population of Australian women.  
Other women in our sample were more willing to swap between management options, their decisions 
most often motivated by a desire to avoid higher risks of breast cancer, or to be involved in decision-
making.  While there is a growing interest in the importance of meta-health effects such as 
convenience (De Abreu Lourenço, 2017), in this study, health effects dominated.  That dominance 
may reflect a response to underlying concerns regarding cancer recurrence, and thus reflect a level of 
reassurance that health measures provide to women in terms of avoiding future cancer risks.  It is also 
possible that the dominance of health effects was a result of respondents adopting simplifying 
heuristics in their decision-making.  Each choice profile contained nine attributes, which might have 
led some respondents to focus only on those attributes they considered important.  Constructing DCE 
designs with attributes in overlapping subsets has been used to test the impact of up to 30 attributes in 
a choice context (A. Muhlbacher & F. Johnson, 2016).  An overlapping design was not used in this 
study due to the likelihood that it would require a much larger sample size.  In the pilot study, 72% of 
respondents indicated that the number of attributes did not influence how they answered the choice 
tasks.  Thus, taking this into account, and that three attributes applied only to the CPM option, it is 
unlikely that the number of attributes adversely affected the results observed. 
Our results indicated that the most important difference between traders and non-traders was the 
extent to which they reported being concerned about cancer recurrence; women who were concerned 
about cancer recurrence were more likely to trade and generally more likely to prefer CPM over 
monitoring.  In contrast, women who were not concerned about cancer recurrence reported that being 
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involved in decision making about their care was more important.  Overall, women were more likely 
to choose options in which they were involved in decisions about their care, supporting the calls made 
by Boughey et al. (2016) for shared decision-making in this setting (J. C. Boughey, Attai, Chen, 
Cody, Dietz, Feldman, Greenberg, Kass, Landercasper, Lemaine, MacNeill, Margenthaler, et al., 
2016).  All respondents indicated that health effects affected their choices, highlighting the 
importance of providing women with adequate information about the potential health effects 
associated with the available options for managing the risk of breast cancer recurrence.  That 
information may have to be tailored to women’s underlying attitudes to the risk of cancer recurrence, 
particularly in light of the potential for the lack of information on breast cancer risk management to 
impact on fear of cancer recurrence (Fardell et al., 2016).   
In this study, latent class analysis was used to identify groups which behaved most similarly in terms 
of their choices.  Such analysis is a potentially powerful means of describing groups displaying 
similar choice behaviour, but, as yet, it is used in less than half of published studies in health care 
(Zhou et al., 2018).   
One potential limitation of our study is that it did not include a specific sample of women with 
experience of breast cancer.  While acknowledging the usefulness of such a sample, we believe their 
exclusion does not diminish the validity of the results given that respondents may be faced with a 
future choice regarding the ongoing management of breast cancer risk.  The salience of this research 
was enhanced through the inclusion of women with experience of breast cancer in its development, 
conduct and interpretation.  In addition, we deliberately excluded a scenario in which women were 
making choices about breast cancer risk in light of a familial or genetic predisposition; in our opinion 
this represents a different decision context, potentially giving rise to a different set of preferences. 
We observed a high degree of non-trading, largely in favour of routine monitoring over CPM.  The 
source of such strong preferences appears to lie in what women understood by the labels we used to 
describe the management options of routine monitoring and CPM.  However, it cannot be discounted 
that some women were motivated to always choose monitoring because there were some attributes 
(surgical OOP, pain risk and sensitivity risk) that applied only to the CPM option.  However, because 
we did not collect specific qualitative data regarding this issue, it was not possible to explore with the 
women who exhibited such strong preferences what motivated their particular choices.  It is also 
possible that women were influenced in their choices by the wording used to label our choice options; 
preliminary pilot and qualitative testing indicated that the wording used in the survey was acceptable 
to women, but we did not explore the extent to which respondents might have inferred meaning in the 
labels beyond what was expressed in the attributes shown.  It is also possible that the choices made by 
some women may have differed if we had included the risk of lymphedema as an attribute, noting that 
lymphedema risk more commonly affected by the method of lymph node dissection during 
mastectomy and has a low incidence among women undergoing contralateral prophylactic 
mastectomy (Geiger et al., 2005; Miller et al., 2012). 
While there have been other DCEs conducted in the field of breast cancer, they have focused on 
preferences for the provision of screening services, follow-up care or surgery (Bessen et al., 2014; 
Caldon, Walters, Ratcliffe, & Reed, 2007; Gerard, Shanahan, & Louviere, 2003).  This is the first 
research to evaluate women’s preferences for how to manage the risks of breast cancer recurrence 
using a DCE, and the first to use a latent class analysis in this setting.  We have not only been able to 
describe differences in the choice behaviour of groups of women, but importantly how these groups 
differ in terms of their demographic characteristics.  Importantly, this included investigating whether 
choices differed depending on whether or not women were concerned about cancer recurrence.  This 
revealed differences across women in terms of the importance to them of achieving reductions in 
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cancer risk – those who were concerned over cancer recurrence had stronger preferences for 
management strategies associated with lower ongoing risks.  Previous research has found high levels 
of health care utilisation among patients who exhibit high levels of concern about disease symptoms 
or illness (Barsky, Orav, & Bates, 2005; Bermingham, Cohen, Hague, & Parsonage, 2010; Mewton & 
Andrews, 2013; Puri & Dimsdale, 2011).  It is plausible that women who are concerned about cancer 
recurrence following breast cancer treatment might use more health care services than those who are 
not similarly concerned.  This is a topic worth exploring in future research.   
Conclusion 
This is the first DCE to investigate women’s preferences for managing ongoing breast cancer risk and 
to consider the role of cancer concern in shaping those preferences.  The research identified that 
women’s preferences about how to manage breast cancer recurrence risk reflect the importance of the 
associated health effects (avoiding ongoing cancer risk), the experience of care (less frequent and less 
invasive monitoring) and attitudes to cancer recurrence (those who were concerned about cancer 
recurrence were least likely to prefer ongoing monitoring as a management option).  Understanding 
that preferences differ based on women’s level of concern about cancer recurrence can be used to 
shape the information provided to them when management options are discussed. 
  




The underlying principle behind DCEs is that goods or services are comprised of attributes, and 
individuals making a choice between those goods or services choose the combination of attributes 
they expect to deliver the highest utility.(Lancaster, 1966)  In its simplest form, those choices can be 
investigated using the following relationship (Keane & Wasi, 2013; McFadden, 1974)   
	 U βx ε    (1) 
where U reflects the utility, or satisfaction, derived by individual i over alternative j at choice t, x are 
the attributes describing the choices and covariates expected to influence choice, and β is the vector of 
homogenous attribute coefficients: it can vary between attributes, but for a given attribute is assumed 
to be the same across individuals.  This analysis can also include variables for the choice labels 
(alternative specific constants; which in our analysis were the labels for profiles describing CPM plus 
monitoring, or monitoring only) as explanatory covariates.(Keane & Wasi, 2013)  In analysing these 
choices we are determining the probability that an individual i will choose an alternative j at each 
choice t, given the attribute levels x describing that choice.  The base model, in (1), assumes 
homogeneity across individuals in determining their preferences, and thus probability of making a 
given choice.  However, based on the results of the qualitative research and preliminary pilot survey, 
we hypothesised that we could categorise respondents into groups based on their preferences between 
routine monitoring and CPM. 
Accordingly, we used latent class analysis(Pacifico & Yoo, 2013) to investigate the choices 
respondents made, taking into account the potential for respondents to be characterised into separate 
groups based on the similarity of their choice behaviour.  The choice probabilities are thus estimated 
according to the following: 
P j g⁄ exp	 β x /∑ exp	 β x  (2)	
where the interpretation of x and β remains as previously, and the probability of an individual 
choosing option j is conditional on their membership of group g; there are 1 to G groups to be 
determined by the model performance criteria, and the attribute coefficients vary between groups 
(Keane & Wasi, 2013). 
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Table 1:  DCE Attributes and Levels 
Attribute Levels 
CBC Risk The chance that you will be diagnosed with 
cancer in your healthy breast some time in the 
next ten years is: 
3 in a 1,000 (0.3%) 
10 in a 1,000 (1%) 
20 in a 1,000 (2%)  
50 in a 1,000 (5%) 
Other BC Risk The chance that your original cancer returns or 
spreads beyond your breasts some time in the 
next ten years is: 
100 in a 1,000 (10%) 
150 in a 1,000 (15%) 
200 in a 1,000 (20%) 
Monitoring 
Type 
In addition to your regular self-checks, you 
will need to have the following tests: 
Mammogram 
MRIs of your breast area 
Ultrasounds of your breast area 
Monitoring 
Frequency 







The cost for monitoring each year is $900, and 
you pay:   
0, 300, 600, 900 
OOP: Surgical The cost for surgery associated with managing 
your ongoing risk of cancer recurrence is 
$15,000, and you pay: 
0, 5000, 10000, 15000 
Pain Risk The chance you will experience ongoing pain 
is: 
400 in 1,000 (40%) 
300 in 1,000 (30%) 
200 in 1,000 (20%) 
100 in 1,000 (10%) 
Sensitivity Risk The chance you will experience an ongoing 
loss of sensitivity in your breast area is: 
600 in 1,000 (60%) 
500 in 1,000 (50%) 
400 in 1,000 (40%) 
300 in 1,000 (30%) 
Decision 
Involvement 
Your medical team involves you in ongoing 
discussions about managing your risk of 
cancer recurrence. 
Always 
Not very often 
Abbreviations:  BC, breast cancer; CBC, contralateral breast cancer; OOP, out-of-pocket 
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Table 2: Respondent demographics 
 Overall Sample Cancer Concerned Australian 
  No Yes Popn. 
 n=464 n=130 n=326  
Age     
16-24 19 (4.09) 6 (4.62) 13 (3.99) (15.62) 
25-44 168 (36.21) 47 (36.15) 120 (36.81) (34.52) 
45-64 175 (37.72) 50 (38.46) 125 (38.34) (30.37) 
65-74 81 (17.46) 21 (16.15) 58 (17.79) (10.45) 
75 or Over 13 (2.8) 5 (3.85) 8 (2.45) (9.05) 
Unknown 8 (1.72) 1 (0.77) 2 (0.61)  
    
Household Income (annum)    
Under $40,000  128 (27.59) 37 (28.46) 89 (27.3) - 
$40,000‐$79,999 116 (25) 31 (23.85) 84 (25.77) - 
$80,000‐$149,999 106 (22.84) 27 (20.77) 79 (24.23) - 
Over $150,000 34 (7.33) 9 (6.92) 25 (7.67) - 
Unknown  80 (17.24) 26 (20) 49 (15.03) - 
Medianth category  1,150-1,529 1,150-1,529 1,150-1,529 1,234 
Education    
School Only 136 (29.31) 35 (26.92) 100 (30.67) (42.62) 
University  141 (30.39) 34 (26.15) 106 (32.52) (27.54) 
Vocational 178 (38.36) 59 (45.38) 118 (36.2) (28.14) 
Unknown 9 (1.94) 2 (1.54) 2 (0.61) n.a. 
    
Residence    
Major City 307 (66.16) 82 (63.08) 224 (68.71) (71.30) 
Inner Regional 89 (19.18) 28 (21.54) 59 (18.1) (18.29) 
Outer Regional 32 (6.9) 10 (7.69) 25 (7.67) (8.68) 
Remote  3 (0.65) 10 (7.69) 18 (5.52) (1.73) 
Unknown  33 (7.11) 82 (63.08) 224 (68.71)  
    
At Least One    
Chronic Health Issue 267 (57.54) 69 (26.64) 190 (73.36) n.a. 
Prior Breast Cancer 16 (3.51) 5 (31.25) 11 (68.75) n.a. 
Note: Population distribution for Australia is based on all non-indigenous persons. 
Abbreviation: n.a., not applicable. 
  




Table 3: Results of Latent Class Analysis (OR) 
Attributes Prefer CPM Traders Prefer Monitoring 
Continuous variables:    
CBC Risk 1.13 (0.78-1.62) 0.81 (0.75-0.87)a 0.97 (0.75-1.25) 
Other BC Risk 0.98 (0.88-1.1) 0.96 (0.94-0.99)b 0.98 (0.91-1.07) 
Monitoring OOP, $'00 1.01 (0.91-1.11) 0.95 (0.93-0.98)a 0.91 (0.84-0.99)b 
Surgery OOP, $'00 0.99 (0.99-1) 0.99 (0.99-1)a 0.99 (0.98-1)b 
Pain Risk 1.03 (0.99-1.08) 0.99 (0.98-1)b 1 (0.97-1.04) 
Sensitivity Risk 1 (0.95-1.05) 0.99 (0.98-1) 0.99 (0.95-1.03) 
Categorical variables:    
Ultrasound: Mammogram 1.27 (0.84-1.94) 1.08 (0.97-1.21) 1.26 (0.93-1.72) 
MRI: Mammogram 1.1 (0.71-1.69) 1.04 (0.94-1.16) 0.89 (0.65-1.23) 
Annual: Biannual Checks 1.29 (0.8-2.09) 0.93 (0.83-1.05) 0.87 (0.6-1.27) 
Biennial: Biannual Checks 0.96 (0.63-1.47) 1.06 (0.96-1.17) 1.08 (0.81-1.44) 
Involved Always: Rarely 1.11 (0.83-1.5) 1.14 (1.05-1.23)b 0.96 (0.76-1.21) 
Monitoring: CPM 0.24 (0.05-1.14)c 0.83 (0.59-1.17) 5.26 (2.24-12.34)a 
Notes: c<0.10; b p<0.05; a p<0.01. 69% of respondents in the Prefer CPM class only ever 
chose CPM Only, a further 16% chose Monitoring Only once, and the remaining respondents 
chose Monitoring Only at most three times.   83% of respondents in the Prefer Monitoring 
class always chose Monitoring Only, a further 15% making only one choice for CPM Only.   
All women in the Traders chose from both options (the minimum for either option being three 
of of 12 choices), with a slight preference for choosing Monitoring Only more frequently than 
CPM Only.  
Base levels for effects coded categorical variables are shown in italics. 
 Models implemented with robust standard errors to account for the survey nature of the data 
and with 1,000 replications per analysis. 
Fit statistics: 11,136 observations over 464 respondents. 
Akaike information criterion 3,617.46, Bayesian information criterion 4,100.44, and pseudo 
R2 0.047.  
Abbreviations: BC, breast cancer; CBC, contralateral breast cancer; CPM, contralateral prophylactic 
mastectomy; MRI, magnetic resonance imaging; OOP, out-of-pocket; OR, odds ratio. 
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Box 1:  Example DCE Choice Set 
SEE ACCOMPANYING PICTURE 
 
After each such choice scenario, women answered the question,  
 
“Which one would you choose? 
o Surgery to remove unaffected breast plus monitoring 
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Figure 1:  Ratings of Attribute Importance  
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